Buccal Drug Delivery Systems Market Size, Trends, Analysis, and Outlook By Type (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others), By End-User (Hospitals, Ambulatory Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Buccal Drug Delivery Systems market size is poised to register 9.88% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Buccal Drug Delivery Systems market across By Type (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others), By End-User (Hospitals, Ambulatory Centers, Others).
The Buccal Drug Delivery Systems Market is experiencing significant growth and innovation in 2024 and beyond, driven by advancements in drug formulation technology, patient-centric drug delivery solutions, and the increasing demand for convenient, non-invasive routes of drug administration for systemic and local therapeutic applications. Buccal drug delivery systems offer several advantages, including rapid drug absorption, avoidance of first-pass metabolism, and sustained drug release, making them suitable for delivering a wide range of pharmaceuticals, including small molecules, peptides, and biologics, for the treatment of various medical conditions, such as pain management, hormone replacement therapy, and smoking cessation. Key trends include the development of mucoadhesive buccal patches, buccal films, and buccal gels that adhere to the oral mucosa, release drugs in a controlled manner, and enhance drug permeation across the buccal membrane, as well as the integration of novel excipients, permeation enhancers, and drug delivery technologies into buccal dosage forms to improve drug bioavailability, pharmacokinetics, and patient compliance in diverse therapeutic areas. Additionally, there is a growing emphasis on personalized medicine approaches, patient-tailored dosing regimens, and precision buccal drug delivery systems that address individual patient needs, preferences, and pharmacogenomic factors to optimize therapeutic outcomes and minimize adverse effects in clinical practice. Moreover, collaborative partnerships between pharmaceutical companies, drug delivery researchers, and regulatory agencies are essential for advancing buccal drug delivery technology, validating clinical safety and efficacy, and commercializing innovative buccal formulations that improve patient outcomes and quality of life in healthcare settings worldwide.
Buccal Drug Delivery Systems Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Buccal Drug Delivery Systems market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Buccal Drug Delivery Systems survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Buccal Drug Delivery Systems industry.
Key market trends defining the global Buccal Drug Delivery Systems demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Buccal Drug Delivery Systems Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Buccal Drug Delivery Systems industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Buccal Drug Delivery Systems companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Buccal Drug Delivery Systems industry
Leading Buccal Drug Delivery Systems companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Buccal Drug Delivery Systems companies.
Buccal Drug Delivery Systems Market Study- Strategic Analysis Review
The Buccal Drug Delivery Systems market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Buccal Drug Delivery Systems industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Buccal Drug Delivery Systems Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Buccal Drug Delivery Systems Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Buccal Drug Delivery Systems market segments. Similarly, Strong end-user demand is encouraging Canadian Buccal Drug Delivery Systems companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Buccal Drug Delivery Systems market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Buccal Drug Delivery Systems Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Buccal Drug Delivery Systems industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Buccal Drug Delivery Systems market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Buccal Drug Delivery Systems Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Buccal Drug Delivery Systems in Asia Pacific. In particular, China, India, and South East Asian Buccal Drug Delivery Systems markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Buccal Drug Delivery Systems Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Buccal Drug Delivery Systems Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Buccal Drug Delivery Systems market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Buccal Drug Delivery Systems.
Buccal Drug Delivery Systems Market Company Profiles
The global Buccal Drug Delivery Systems market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ARx LLC, BioDelivery Sciences International Inc, Catalent, Cynapsus Therapeutics Inc, Endo Pharmaceuticals plc, Generex Biotechnology, GlaxoSmithKline plc, Indivior Pharmaceuticals, Pfizer Inc, Teva Pharmaceutical Industries Ltd
Recent Buccal Drug Delivery Systems Market Developments
The global Buccal Drug Delivery Systems market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Buccal Drug Delivery Systems Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others
Geographical Segmentation:
ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
The Buccal Drug Delivery Systems Market is experiencing significant growth and innovation in 2024 and beyond, driven by advancements in drug formulation technology, patient-centric drug delivery solutions, and the increasing demand for convenient, non-invasive routes of drug administration for systemic and local therapeutic applications. Buccal drug delivery systems offer several advantages, including rapid drug absorption, avoidance of first-pass metabolism, and sustained drug release, making them suitable for delivering a wide range of pharmaceuticals, including small molecules, peptides, and biologics, for the treatment of various medical conditions, such as pain management, hormone replacement therapy, and smoking cessation. Key trends include the development of mucoadhesive buccal patches, buccal films, and buccal gels that adhere to the oral mucosa, release drugs in a controlled manner, and enhance drug permeation across the buccal membrane, as well as the integration of novel excipients, permeation enhancers, and drug delivery technologies into buccal dosage forms to improve drug bioavailability, pharmacokinetics, and patient compliance in diverse therapeutic areas. Additionally, there is a growing emphasis on personalized medicine approaches, patient-tailored dosing regimens, and precision buccal drug delivery systems that address individual patient needs, preferences, and pharmacogenomic factors to optimize therapeutic outcomes and minimize adverse effects in clinical practice. Moreover, collaborative partnerships between pharmaceutical companies, drug delivery researchers, and regulatory agencies are essential for advancing buccal drug delivery technology, validating clinical safety and efficacy, and commercializing innovative buccal formulations that improve patient outcomes and quality of life in healthcare settings worldwide.
Buccal Drug Delivery Systems Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Buccal Drug Delivery Systems market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Buccal Drug Delivery Systems survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Buccal Drug Delivery Systems industry.
Key market trends defining the global Buccal Drug Delivery Systems demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Buccal Drug Delivery Systems Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Buccal Drug Delivery Systems industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Buccal Drug Delivery Systems companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Buccal Drug Delivery Systems industry
Leading Buccal Drug Delivery Systems companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Buccal Drug Delivery Systems companies.
Buccal Drug Delivery Systems Market Study- Strategic Analysis Review
The Buccal Drug Delivery Systems market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Buccal Drug Delivery Systems industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Buccal Drug Delivery Systems Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Buccal Drug Delivery Systems Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Buccal Drug Delivery Systems market segments. Similarly, Strong end-user demand is encouraging Canadian Buccal Drug Delivery Systems companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Buccal Drug Delivery Systems market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Buccal Drug Delivery Systems Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Buccal Drug Delivery Systems industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Buccal Drug Delivery Systems market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Buccal Drug Delivery Systems Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Buccal Drug Delivery Systems in Asia Pacific. In particular, China, India, and South East Asian Buccal Drug Delivery Systems markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Buccal Drug Delivery Systems Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Buccal Drug Delivery Systems Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Buccal Drug Delivery Systems market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Buccal Drug Delivery Systems.
Buccal Drug Delivery Systems Market Company Profiles
The global Buccal Drug Delivery Systems market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ARx LLC, BioDelivery Sciences International Inc, Catalent, Cynapsus Therapeutics Inc, Endo Pharmaceuticals plc, Generex Biotechnology, GlaxoSmithKline plc, Indivior Pharmaceuticals, Pfizer Inc, Teva Pharmaceutical Industries Ltd
Recent Buccal Drug Delivery Systems Market Developments
The global Buccal Drug Delivery Systems market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Buccal Drug Delivery Systems Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Buccal Drug Delivery Systems Market Overview and Key Findings, 2024
1.2 Buccal Drug Delivery Systems Market Size and Growth Outlook, 2021- 2030
1.3 Buccal Drug Delivery Systems Market Growth Opportunities to 2030
1.4 Key Buccal Drug Delivery Systems Market Trends and Challenges
1.4.1 Buccal Drug Delivery Systems Market Drivers and Trends
1.4.2 Buccal Drug Delivery Systems Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Buccal Drug Delivery Systems Companies
2. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE OUTLOOK TO 2030
2.1 Buccal Drug Delivery Systems Market Size Outlook, USD Million, 2021- 2030
2.2 Buccal Drug Delivery Systems Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BUCCAL DRUG DELIVERY SYSTEMS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BUCCAL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Buccal Drug Delivery Systems Market, 2025
5.2 Asia Pacific Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Buccal Drug Delivery Systems Market, 2025
5.5 Europe Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.6 Europe Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Buccal Drug Delivery Systems Market, 2025
5.8 North America Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.9 North America Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Buccal Drug Delivery Systems Market, 2025
5.11 South America Pacific Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.12 South America Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Buccal Drug Delivery Systems Market, 2025
5.14 Middle East Africa Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Buccal Drug Delivery Systems Market Size Outlook and Revenue Growth Forecasts
6.2 US Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Buccal Drug Delivery Systems Industry Drivers and Opportunities
7. BUCCAL DRUG DELIVERY SYSTEMS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BUCCAL DRUG DELIVERY SYSTEMS COMPANY PROFILES
8.1 Profiles of Leading Buccal Drug Delivery Systems Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Buccal Drug Delivery Systems Market Overview and Key Findings, 2024
1.2 Buccal Drug Delivery Systems Market Size and Growth Outlook, 2021- 2030
1.3 Buccal Drug Delivery Systems Market Growth Opportunities to 2030
1.4 Key Buccal Drug Delivery Systems Market Trends and Challenges
1.4.1 Buccal Drug Delivery Systems Market Drivers and Trends
1.4.2 Buccal Drug Delivery Systems Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Buccal Drug Delivery Systems Companies
2. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE OUTLOOK TO 2030
2.1 Buccal Drug Delivery Systems Market Size Outlook, USD Million, 2021- 2030
2.2 Buccal Drug Delivery Systems Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BUCCAL DRUG DELIVERY SYSTEMS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BUCCAL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Sublingual Films
Buccal Tablets and Lozenges
Oral Sprays
By Application
Pain Management
Smoking Cessation
Angina Pectoris
Others
By End-user
Hospitals
Ambulatory Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Buccal Drug Delivery Systems Market, 2025
5.2 Asia Pacific Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Buccal Drug Delivery Systems Market, 2025
5.5 Europe Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.6 Europe Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Buccal Drug Delivery Systems Market, 2025
5.8 North America Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.9 North America Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Buccal Drug Delivery Systems Market, 2025
5.11 South America Pacific Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.12 South America Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Buccal Drug Delivery Systems Market, 2025
5.14 Middle East Africa Buccal Drug Delivery Systems Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Buccal Drug Delivery Systems Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Buccal Drug Delivery Systems Market Size Outlook and Revenue Growth Forecasts
6.2 US Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Buccal Drug Delivery Systems Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Buccal Drug Delivery Systems Industry Drivers and Opportunities
7. BUCCAL DRUG DELIVERY SYSTEMS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BUCCAL DRUG DELIVERY SYSTEMS COMPANY PROFILES
8.1 Profiles of Leading Buccal Drug Delivery Systems Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
ARx LLC
BioDelivery Sciences International Inc
Catalent
Cynapsus Therapeutics Inc
Endo Pharmaceuticals plc
Generex Biotechnology
GlaxoSmithKline plc
Indivior Pharmaceuticals
Pfizer Inc
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
